GNAI2 and myeloid sarcoma: They demonstrated that the expression of the migration-promoting genes HSP90B1, GNAI2, and S1PR1 was positively correlated with their ability to migrate to the CNS, whereas the negative regulator ETS1 exhibited a negative correlation with the migratory ability of CD4+ T cells from MS patients (96).